Skip to main content

Featured article and editorial: incorporating lettuce or watercress into your diet

New Content Item (1)We are proud to publish a new article by Javad Nasrollahzadeh and co-authors, and an associated editorial by Gregory C. Henderson. Postprandial responses to food mostly depend on the composition of the meal and the consumption of vegetables may modulate this postprandial state. In this study, the effects of lettuce or watercress consumption with a moderately high-fat meal (40% kcal from fat) on postprandial lipemia, glycemia, and inflammatory cytokines were determined in healthy men.

Call for Papers: Lipids and Women’s Health

New Content Item (1)We are calling for submissions to our new Collection on "Lipids and Women’s Health" which will explore two thematic areas: Lipids in Reproductive Diseases in Women and Influence of Gender Bias on Recent Lipid Studies. Read more about the scope here.

Featured series: Lipids and Sleep

New Content Item (1)Lipids in Health and Disease is calling for submissions to our new Collection on "Lipids and Sleep". This Collection is focusing on the link between sleep and lipid metabolism. We invite original research, topical and systematic review articles and meta-analyses. For more information on the scope please click here.

Featured series: Nanomaterials/Biomaterials Target Lipid Metabolism and Fight Diseases

New Content Item (1)Lipids in Health and Disease is calling for submissions to our new Collection on "Nanomaterials/Biomaterials Target Lipid Metabolism and Fight Diseases". With this Collection we hope to provide a platform for communication and discussion of the pharmacological mechanism of nanobiotechnology and lipid metabolism. Read more about the scope here.

Featured series: Lipid Metabolism in Nonalcoholic Fatty Liver Disease

New Content Item (1)We are calling for submissions to our new Collection which will highlight several topics including: early detection of nonalcoholic fatty liver disease (NAFLD), current therapy for NAFLD, new targets for treating NAFLD, treatment to reduce cardiovascular risks associated with NAFLD, and translational implications and challenges of lipid metabolism in NAFLD. Read more about the scope here.

Featured series: Lipid Abnormalities in ASD and ASD-Associated Genetic Disorders and the Associated mTOR Pathway

New Content Item (1)We are calling for submissions to our new Collection which will highlight lipid abnormalities identified in autism spectrum disorder (ASD) and ASD-associated genetic disorders, including Smith Lemli Opitz syndrome, Rett syndrome, fragile X syndrome, tuberous sclerosis, neurofibromatosis types 1 and 2, Angelman syndrome, Down syndrome and PTEN hamartoma tumor syndrome and the relationship of ASD-associated genetic disorders to the mTOR pathway. Read more here.

Top-Altmetric articles

New Content Item (1)Please check out the LHAD articles with the highest Altmetric scores, since our journal launched in 2002. Altmetric calculates a score based on the online attention an article receives. Social media and mainstream news media are the main sources that calculate the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.

Top articles of 2021

New Content Item (1)Please be sure to take a look at some of the top content published in Lipids in Health and Disease this year, thus far! Articles which performed well as far as citations, Altmetrics, and accesses are included.

Have a submission for Lipids in Health and Disease?

Have a submission you want to make sure is right for Lipids in Health and Disease? Or a great idea for a new submission or thematic series? Tell our Editor-in-Chief, A. M. Abd El-Aty!



A. M. Abd El-Aty, Cairo University, Egypt

Aims and scope

Lipids in Health and Disease is an open access, peer-reviewed journal that publishes articles on all aspects of lipids: their interaction with proteins, (bio) chemistry, (molecular) pharmacology, (molecular) toxicology, natural products chemistry, role in health and disease, in addition to the synthesis of new lipid compounds, and enzyme systems involved in lipid metabolism.

Lipids in Health and Disease is aimed at all scientists, health professionals, and physicians interested in lipids. Lipids are defined herein based on their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes, and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology, and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.

Reviewers of the quarter

Lipids in Health and Disease is pleased to implement a new platform of recognition every quarter, for the peer reviewers who provided the best performance along the parameters of acceptance rate, scrutiny of the reviews, completion, accepted-completion %, On time delivery-Completion %, and our Editor-in-Chief's evaluation rate. Please click here, to learn about our Reviewers of the Quarter.

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,488 Altmetric mentions